Quantitative Expression of SFN, lncRNA CCDC18-AS1, and lncRNA LINC01343 in Human Breast Cancer as the Regulator Biomarkers in a Novel ceRNA Network: Based on Bioinformatics and Experimental Analyses

Table 1

The pathological characteristics of patients.

Characteristics	Status	Number of patients
Stage	I	1 (4.2%)
	II	9 (37.6%)
	III	10 (41.6%)
	IV	0
	Unknown	4 (16.6%)
Age	<45	11 (45.8%)
	>45	13 (54.2%)
	Unknown	0 (0%)
Tumor size (TS)	<5 cm	14 (58.4%)
	>5 cm	6 (25%)
	Unknown	4 (16.6%)
Menopausal status	Yes	11 (45.8%)
	No	12 (50%)
	Unknown	1 (4.2%)
Lymph node	Yes	17 (70.8%)
	No	3 (12.6%)
	Unknown	4 (16.6%)
ER receptor	Positive	10 (41.6%)
	Negative	6 (25%)
	Unknown	8 (33.4%)
PR receptor	Positive	8 (33.4%)
	Negative	8 (33.4%)
	Unknown	8 (33.4%)
HER2/neu receptor	Positive	8 (33.4%)
	Negative	8 (33.4%)
	Unknown	8 (33.4%)